Zdrowie i gospodarka · 27/08/2014
FDA Corrects Biosimilar User Fee Rates Notice
The Food and Drug Administration is correcting a notice regarding biosimilar user fee rates for fiscal year 2015, which was published with an incorrect docket number in the Federal Register on August 1, 2014.